Full View

NLRP3 inflammasome and the IL-1 pathway in atherosclerosis

A Grebe, F Hoss, E Latz - Circulation research, 2018 - Am Heart Assoc
Inflammation is an important driver of atherosclerosis, the underlying pathology of
cardiovascular diseases. Therefore, therapeutic targeting of inflammatory pathways is …
被引用次数：670 相关文章

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis

A Grebe, F Hoss, E Latz - Circulation Research, 2018 - cir.nii.ac.jp
抄録< jats: p> Inflammation is an important driver of atherosclerosis, the underlying
pathology of cardiovascular diseases. Therefore, therapeutic targeting of inflammatory …

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.

A Grebe, F Hoss, E Latz - Circulation Research, 2018 - europepmc.org
Inflammation is an important driver of atherosclerosis, the underlying pathology of
cardiovascular diseases. Therefore, therapeutic targeting of inflammatory pathways is …

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.

A Grebe, F Hoss, E Latz - Circulation research, 2018 - pub.dzne.de
Inflammation is an important driver of atherosclerosis, the underlying pathology of
cardiovascular diseases. Therefore, therapeutic targeting of inflammatory pathways is …

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis

A Grebe, F Hoss, E Latz - Circulation research, 2018 - pubmed.ncbi.nlm.nih.gov
Inflammation is an important driver of atherosclerosis, the underlying pathology of
cardiovascular diseases. Therefore, therapeutic targeting of inflammatory pathways is …